°®ÍþÄÌapp

Close

Professor Alison Elliott

Professor of Tropical Medicine

United Kingdom

Tel.
+44 207 927 2116

Alison Elliott is theme leader for Vaccine Research at the MRC/Uganda Virus Research Institute (UVRI) and LSHTM Uganda Research Unit and Professor of Tropical Medicine at the °®ÍþÄÌapp of Hygiene & Tropical Medicine. She leads the NIHR Global Health Group on Vaccines for vulnerable people in Africa, and the NIH Tropical Medicine Research Center the "Uganda multidisciplinary schistosomiasis research center". From 2008-2022 she was director of the Makerere University – UVRI Centre of Excellence for Infection and Immunity Research and Training.

Affiliations

Department of Clinical Research
Faculty of Infectious and Tropical Diseases

°®ÍþÄÌapp

Malaria Centre
TB Centre
Vaccine Centre

Teaching

Alison's main contribution is through collaborative research capacity strenthening in Uganda. In 2008 she established the Makerere University-Uganda Virus Research Institute (UVRI) Centre of Excellence for Infection and Immunity (MUII), harnessing international partnerships: LSHTM was a lead partner, and MUII was a founder-member of Cambridge Africa. Focussing on immunology and bioinformatics, MUII developed laboratories at Makerere Univerity and at the Uganda Virus Research Institute, and supported the development of a Makerere Master's degree in Immunology and Clinical Microbiology, a UVRI internship programme which has supported over 1600 students, and a fellowship programme which, together with follow-on programmes, has supported over 70 Masters, PhD, post-doctoral and group-lead scientists. 

Research

She became interested in parasitology and research in Africa as an undergraduate and this interest was encouraged further by an elective in The Gambia. After completing medical training she joined the °®ÍþÄÌapp of Hygiene & Tropical Medicine and, during the late ‘80s and early ‘90s, undertook studies on the interaction between tuberculosis and HIV infection in Zambia. An infectious diseases fellowship in Denver, Colorado, followed, providing an opportunity to learn about management of drug resistant tuberculosis and about laboratory immunology. This enabled her to plan and conduct subsequent clinical-immuno-epidemiological studies. Since 1997 she has been based in Uganda at the MRC/UVRI and LSHTM Uganda Unit. Current interests focus on the effects of chronic, immunomodulating infections (such as helminth infections) on immune responses to vaccines and on infectious and allergic disease incidence in children in Uganda; and on research capacity strengthening in Africa.

Research Area
Clinical trials
Global Health
Helminths
Immunisation
Parasites
Vaccines
Vector control
Immunoepidemiology
Disease and Health Conditions
Allergy
HIV/AIDS
Neglected Tropical Diseases (NTDs)
Schistosomiasis
Tropical diseases
Tuberculosis
Infectious diseases
Vector borne diseases
Country
Uganda
Zambia
Region
Sub-Saharan Africa (developing only)

Selected Publications

CRESSWELL, FV; Meya, DB; Kagimu, E; GRINT, D; Te Brake, L; Kasibante, J; Martyn, E; Rutakingirwa, M; Quinn, CM; Okirwoth, M; Tugume, L; Ssembambulidde, K; Musubire, AK; Bangdiwala, AS; Buzibye, A; Muzoora, C; Svensson, EM; Aarnoutse, R; Boulware, DR; ELLIOTT, AM;
2021
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Driciru, E; Koopman, JP R; COSE, S; Siddiqui, AA; Yazdanbakhsh, M; ELLIOTT, AM; Roestenberg, M;
2021
Frontiers in immunology
Muriuki, JM; Mentzer, AJ; Mitchell, R; WEBB, EL; Etyang, AO; Kyobutungi, C; Morovat, A; Kimita, W; Ndungu, FM; Macharia, AW; Ngetsa, CJ; Makale, J; Lule, SA; Musani, SK; Raffield, LM; Cutland, CL; Sirima, SB; Diarra, A; Tiono, AB; Fried, M; Gwamaka, M; Adu-Afarwuah, S; Wirth, JP; Wegmüller, R; Madhi, SA; ... Atkinson, SH.
2021
Nature medicine
PRENTICE, S; Nassanga, B; WEBB, EL; Akello, F; Kiwudhu, F; Akurut, H; ELLIOTT, AM; Arts, RJ W; Netea, MG; DOCKRELL, HM; COSE, S; Delayed BCG Study Team,;
2021
The Lancet. Infectious diseases
NKURUNUNGI, G; ZIRIMENYA, L; NATUKUNDA, A; Nassuuna, J; Oduru, G; Ninsiima, C; Zziwa, C; Akello, F; Kizindo, R; Akello, M; KALEEBU, P; WAJJA, A; Luzze, H; COSE, S; WEBB, E; ELLIOTT, AM; POPVAC trial team,;
2021
BMJ open
NKURUNUNGI, G; MPAIRWE, H; Versteeg, SA; Van Diepen, A; Nassuuna, J; Kabagenyi, J; Nambuya, I; Sanya, RE; Nampijja, M; Serna, S; Reichardt, N-C; Hokke, CH; WEBB, EL; Van Ree, R; Yazdanbakhsh, M; ELLIOTT, AM;
2020
ALLERGY
Lubyayi, L; Mawa, PA; Nabakooza, G; Nakibuule, M; Tushabe, JV; Serubanja, J; Aibo, D; Akurut, H; Tumusiime, J; Hasso-Agopsowicz, M; KALEEBU, P; Levin, J; DOCKRELL, HM; Smith, S; WEBB, EL; ELLIOTT, AM; COSE, S;
2020
FRONTIERS IN IMMUNOLOGY
Etyang, T; ZIRIMENYA, L; Njue, M; NALWANGA, R; Zalwango, F; Abuga, KM; Karanja, HK; Mumba, N; Owino, EA; Eoju, W; Kukundakwe, C; Nsubuga, D; Baine, C; Walusimbi, B; NKURUNUNGI, G; Natukunda, A; Chibita, M; Mafigiri, DK; Kamuya, D; Atkinson, S; Chi, P; WEBB, EL; Trotter, CL; Kaleebu, P; ELLIOTT, AM;
2025
NIHR open research
Liu, E; Partap, U; Shinde, S; Wang, D; Costa, JC; Cliffer, IR; Wang, M; Nookala, SK; Subramoney, V; Briggs, B; Hamer, DH; Akurut, H; Argaw, A; Ashorn, U; Chinkhumba, J; Desai, M; Divala, TH; ELLIOTT, AM; Gutman, JR; Hien, A; Huybregts, L; Kajubi, R; Kakuru, A; Kariuki, S; Lachat, C; ... Fawzi, WW.
2025
EClinicalMedicine
BUSTINDUY, AL; EDIELU, A; Ayebazibwe, GK; Nakyesige, R; Anguajibi, V; Mpooya, S; Nassuna, J; Adriko, M; ELLIOTT, A; Van Dam, G; Corstjens, P; Pach, S; Wu, H; Colt, S; Mawa, PA; Muheki, E; Kabatereine, NB; WEBB, EL; Friedman, JF;
2025
The Lancet Global health